Pharmaceutical Label Market Report 2026

The pharmaceutical label market size has grown strongly in recent years. It will grow from $7.21 billion in 2025 to $7.82 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing pharmaceutical manufacturing activities, rising regulatory labeling requirements, increasing need for drug traceability, expanding prescription medication usage, strengthening focus on patient information safety.

The pharmaceutical label market size is expected to see strong growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for secure labeling technologies, rising adoption of smart connected labels, growing emphasis on sustainability in labeling materials, expansion of biologics and specialty drugs, strengthening regulatory compliance expectations. Major trends in the forecast period include increasing adoption of smart and digital pharmaceutical labels, rising demand for tamper evident and secure labeling solutions, growing shift toward sustainable and eco friendly label materials, expansion of high precision printing technologies in pharma labeling, strengthening emphasis on patient safety and regulatory compliance.

The expansion of the pharmaceutical industry is expected to support the growth of the pharmaceutical label market in the coming years. The pharmaceutical industry includes activities related to the research, development, manufacturing, and commercialization of medicinal drugs used to treat, prevent, or manage diseases and health conditions. Pharmaceutical labeling plays a crucial role in tracking and tracing products throughout the supply chain, ensuring timely distribution while minimizing the risk of counterfeit medicines entering the market. For example, in April 2025, data from Eurostat, a Luxembourg-based government agency, indicated that in 2024, exports of medicinal and pharmaceutical products from the European Union increased by 13.5% compared with 2023, reaching $316.38 billion (€313.4 billion). During the same period, imports rose only marginally by 0.5%, totaling $112.7 billion (€119.7 billion). Consequently, the growth of the pharmaceutical industry is driving the expansion of the pharmaceutical label market.

Leading companies operating in the pharmaceutical labeling market are focusing on the development of innovative solutions, such as AD XeroLinr DT, to improve sustainability and productivity. AD XeroLinr DT is a sustainable, linerless labeling solution designed for variable information (VI) applications. For instance, in March 2023, Avery Dennison, a US-based adhesive manufacturing company, introduced AD XeroLinr DT to help reduce overall logistics time and costs while setting new benchmarks for innovation, sustainability, and regeneration across the supply chain. AD XeroLinr DT delivers enhanced productivity, improved safety, and increased sustainability while maintaining the high performance and quality associated with Avery Dennison products. The solution is engineered to minimize waste and material usage, offering an efficient and environmentally responsible alternative for VI labeling. It is FSC-certified and phenol-free, reflecting the company’s commitment to advancing sustainable practices within the packaging and labeling industry. The launch of AD XeroLinr DT highlights Avery Dennison’s continued focus on innovation and sustainability in labeling solutions.

In August 2023, CCL Industries Inc., a Canada-based specialty labels and packaging manufacturer, acquired Faubel & Co. Nachfolger GmbH for $185.9 million. Through this acquisition, CCL Industries strengthened its presence in the global healthcare labeling market by expanding operational capabilities in Europe and enhancing its pharmaceutical clinical trials labeling portfolio. Faubel & Co. Nachfolger GmbH is a Germany-based specialty manufacturer that focuses on pharmaceutical clinical trial labels and advanced labeling solutions, including next-generation technologies such as RFID developed through its technology subsidiary.

Major companies operating in the pharmaceutical label market report are CCL Industries Inc., Essentra plc, Avery Dennison Corporation, Multi-Color Corporation, SATO Holding Corporation, LINTEC Corporation, Schreiner Group, Constantia Flexibles Group GmbH, Consolidated Label Co., Advanced Labels, Edwards Label Inc., Clabro Label Inc, Metro Label, WS Packaging Group Inc., Inland Label and Marketing Services LLC, MPI Label Systems Inc., Resource Label Group LLC, Smyth Companies LLC, The Kennedy Group Inc., Walle Corporation, Coast Label Company, Amcor Limited, Gerresheimer AG, Berry Global Inc.

North America was the largest region in the pharmaceutical label market in 2025. The regions covered in the pharmaceutical label market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical label market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical label market consists of sales of drug facts labels and professional labeling. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.